News

Forty-five percent of providers interviewed by KLAS are planning to consolidate their CVIS products, but less than half plan to stick with their current vendor/solution. 

implantable cardioverter defibrillator, ep lab, leads, implantable devices

A new study evaluating Optim-insulated implantable cardioverter defibrillator (ICD) leads found low rates of all-cause mechanical failure during a median follow-up of 3.2 years.

Boston Scientific, EVOLVE II, Synergy, bioresorbable stent

In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific Synergy everolimus-eluting bioabsorbable polymer platinum chromium coronary stent system met its...

Endurant IIs, stent graft system, abdominal aortic aneurysm, AAA

Medtronic Inc. announced the launch in Europe and the United States of the Endurant IIs AAA stent graft, which received CE mark and U.S. Food and Drug Administration approval to be used in...

Stethoscope, cardiac diagnostics

Stethoscope provides high acoustic sensitivity for performing general physical assessments

MRI systems, RSNA 2014, MAGNETOM Amira

Siemens Healthcare plans to expand its portfolio of magnetic resonance imaging (MRI) systems to include the Magnetom Amira 1.5 Tesla system, which the company introduced at RSNA 2014.

CardioKinetix Inc. announced it has completed a $50 million financing led by Edwards Lifesciences Corp. with participation from other existing investors. This financing provides CardioKinetix with...

near-infrared spectroscopy, NIRS, heart attack, stroke, Infraredx, TVC

A study published in the Journal of the American College of Cardiology (JACC) shows intravascular near-infrared spectroscopy (NIRS) can identify lipid core-containing plaques,...

Stem cell therapies, heart failure, bone marrow cells, clinical trial

CardioCell LLC announced the treatment of its first patient in the University of Pennsylvania’s Phase IIa clinical trial for chronic heart failure (HF) of non-ischemic cardiomyopathy. 

Radiation dose management, RSNA 2014, x-ray, lead-free, acrylic shielding

Turner MedTech introduced ClearShield at RSNA, which is lead-free, eco-friendly, utilizes no lead and complies with European Union RoHS requirements. 

COR Medical Technologies (COR) introduces CORcare, a comprehensive instant outcome support system for rapid and accurate diagnosis, treatment, and follow-up management of patients with acute and...

Children’s hospitals in the United States delivering the highest-quality care for children undergoing heart surgery also appear to provide care most efficiently at a low cost, according to...

cardiovascular surgery, atrial fibrillation, Minneapolis Heart Institute Found.

Researchers at the Minneapolis Heart Institute Foundation have found that when care teams started following a new set of guidelines for certain patients recovering from cardiovascular surgery...

marijuana use, clinical trial, secondhand smoke, cardiac diagnostics

Breathing secondhand marijuana smoke could damage heart and blood vessels as much as secondhand cigarette smoke, according to preliminary research presented at the American Heart...

BioCardia Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s application to begin a Phase III clinical trial of its bone marrow-derived CardiAMP...

Most patients with implantable cardioverter defibrillators (ICDs) haven’t thought about device deactivation if they were to develop a serious illness from which they were not expected to recover...

interventional radiology, placenta accreta, RSNA, study

Researchers reported on a procedure that can preserve fertility and potentially save the lives of women with a serious pregnancy complication called placenta accreta. Results of the new study...

Clinical Trial, Heart valve repair, TAVR

New research from the Minneapolis Heart Institute Foundation has uncovered a way to help interventional cardiologists better predict which patients are at higher risk for death following TAVR,...

According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with...

Results from a new study indicate that the addition of mitral valve (MV) repair to coronary artery bypass grafting (CABG) did not result in significant benefit to the patient and was associated...